There are studies to prove that derivatives of secondary metabolites can play an anticancer effect by regulating the STAT3 pathway, and show cytotoxicity to cancer cells but no toxicity to non-cancer cell lines, which may inspire development of new drug-like substances with improved cytotoxicity on cancer [21−23]. Here, STAT3 is linked to cancer.